Abstract Centromeres are unique chromosomal loci that promote the assembly of kinetochores, macromolecular complexes that bind spindle microtubules during mitosis. In most organisms, centromeres lack defined genetic features. Rather, they are specified epigenetically by a centromere-specific histone H3 variant, CENP-A. The Mis18 complex, comprising the Mis18a: Mis18b subcomplex and M18BP1, is crucial for CENP-A homeostasis. It recruits the CENP-Aspecific chaperone HJURP to centromeres and primes it for CENP-A loading. We report here that a specific arrangement of Yippee domains in a human Mis18a:Mis18b 4:2 hexamer binds two copies of M18BP1 through M18BP1's 140 N-terminal residues. Phosphorylation by Cyclin-dependent kinase 1 (CDK1) at two conserved sites in this region destabilizes binding to Mis18a:Mis18b, limiting complex formation to the G1 phase of the cell cycle. Using an improved viral 2A peptide co-expression strategy, we demonstrate that CDK1 controls Mis18 complex recruitment to centromeres by regulating oligomerization of M18BP1 through the Mis18a:Mis18b scaffold.
Introduction
In all eukaryotes, faithful chromosome duplication and segregation to the daughter cells is essential for cell viability and development. During mitosis, chromosomes bi-orient on the mitotic spindle, a structure made of microtubules, microtubule motors, and microtubule-binding proteins (Heald and Khodjakov, 2015) . Chromosomes attach to spindle microtubules through large multisubunit assemblies known as kinetochores (Pesenti et al., 2016) . Besides microtubule binding, kinetochores harness a poorly understood molecular mechanism of 'error correction' that leads to selective stabilization of bi-oriented attachments (Foley and Kapoor, 2013) . Upon completion of bi-orientation, removal of sister chromatid cohesion allows the separation of the sister chromatids to the two newly forming daughter cells.
How kinetochores assemble, and how their position on chromosomes is maintained generation after generation, is an important and partly unresolved challenge. Kinetochores assemble on centromeres, unique chromosomal loci characterized by a strong enrichment of the histone H3 variant centromere protein A (CENP-A) (Earnshaw and Rothfield, 1985) . Centromeres in different organisms often consist of long arrays of repetitive sequences, such as the human 171-basepair a-satellite repeats (Fukagawa and Earnshaw, 2014; McKinley and Cheeseman, 2016) . However, centromeres are often found associated with non-repetitive and non-evolutionarily conserved sequences in different organisms. Furthermore, there are instances in humans and other species of neo-centromeres that become established on non-repetitive sequences (Fukagawa and Earnshaw, 2014; McKinley and Cheeseman, 2016) . These examples indicate that the sequence of centromeric DNA contributes only marginally to centromere identity.
There is now general agreement that CENP-A itself is an epigenetic factor for specification of centromeres (Cleveland et al., 2003; De Rop et al., 2012; Stellfox et al., 2013) . CENP-A is required for the recruitment of several inner (centromere-proximal) kinetochore proteins, now generally referred to as constitutive centromere associated network (CCAN) (Foltz et al., 2006; Hori et al., 2008; Izuta et al., 2006; Obuse et al., 2004; Okada et al., 2006) , and thus acts as the kinetochore's foundation. CENP-A, together with other CCAN proteins, also promotes the recruitment of specialized machinery devoted to its own incorporation in chromatin (Fukagawa and Earnshaw, 2014; McKinley and Cheeseman, 2016) . This limits incorporation of new CENP-A to the position of the existing CENP-A domain, thus preserving centromere identity. Importantly, the amount of CENP-A at centromeres is halved during DNA replication, and the ensuing CENP-A 'vacancy' may be filled with histone H3.3 (Dunleavy et al., 2011) . The reduction in CENP-A is compensated with new CENP-A deposition after cell division, in the G1 phase of the cell cycle (Bodor et al., 2014; Jansen et al., 2007; Shelby et al., 2000) , likely in a reaction that replaces H3.3 with CENP-A.
The Mis18 complex is an evolutionarily conserved functional unit of the CENP-A loading machinery (Fujita et al., 2007; Hayashi et al., 2014 Hayashi et al., , 2004 . Vertebrate Mis18 complex consists of Mis18a and Mis18b, which are non-redundant and physically interacting paralogs, and M18BP1 (also known as KNL2) (Fujita et al., 2007) . The Mis18 complex interacts with the CENP-A-specific chaperone HJURP (Dunleavy et al., 2009; Foltz et al., 2009; Nardi et al., 2016; Wang et al., 2014) and with CCAN subunits (Dambacher et al., 2012; Hori et al., 2013; Moree et al., 2011; Shono et al., 2015; Stellfox et al., 2016 ) ( Figure 1A ). Interactions of this machinery enable the recruitment of new CENP-A to already existing centromeres.
M18BP1 is an 1132-residue protein whose sequence is predicted to be largely unstructured. It contains a conserved 50-residue SANT (Swi3, Ada2, N-CoR, and TFIIIB) domain and a 100-residue SANT-associated (SANTA) domain (Boyer et al., 2004; Fujita et al., 2007; Maddox et al., 2007; Zhang et al., 2006 ) ( Figure 1B) . The high content of unstructured regions suggests that M18BP1 functions as a hub for multiple protein-protein interactions. Indeed, CENP-C, CENP-I, Polo-like kinase 1 (Plk1), MgcRacGAP, and the histone acetyl transferase (HAT) KAT7 are suggested to interact with M18BP1 (Dambacher et al., 2012; Lagana et al., 2010; McKinley and Cheeseman, 2014; Moree et al., 2011; Ohzeki et al., 2016; Shono et al., 2015) , but the molecular details of these interactions remain poorly defined.
On the other hand, significant progress has been made in the characterization of the interaction of M18BP1 with Mis18a and Mis18b. Mis18a and Mis18b have similar domain structures, with an N-terminal unstructured region, a Yippee domain in the middle region, and a C-terminal coiled-coil. Recent studies of the single Schizosaccharomyces pombe Mis18 ortholog and of the human Mis18a: Mis18b complex suggested that Mis18 proteins form tetramers Subramanian et al., 2016) . A segment of M18BP1 comprising~380 N-terminal residues was shown to be responsible for a physical interaction with the Mis18a:Mis18b complex (Ohzeki et al., 2016; Stellfox et al., 2016) .
The assembly of the CENP-A deposition machinery in the G1 phase is regulated by inhibitory CDK phosphorylation of CENP-A (Yu et al., 2015) , HJURP (Müller et al., 2014; Wang et al., 2014) , and M18BP1 (McKinley and Cheeseman, 2014; Silva et al., 2012) . Moderate CDK activity through the S and G2 phases and high CDK activity in M phase of the cell cycle keep the CENP-A loading machinery disassembled (Silva et al., 2012) . Degradation of Cyclin B at anaphase and the ensuing decline in CDK activity reverts this condition, allowing physical interactions of the CENP-A loading machinery. The Mis18 complex starts localizing to the CENP-A domain from anaphase and recruits HJURP and new CENP-A in early G1 phase (Dunleavy et al., 2009; McKinley and Cheeseman, 2014; Nardi et al., 2016) . Functionally relevant CDK phosphorylation sites in CENP-A and HJURP were identified (Müller et al., 2014; Yu et al., 2015) , but those in M18BP1 (show in Figure 1 -figure supplement 1) remain functionally uncharacterized.
In this study, we report that two copies of M18BP1 bind an hexameric Mis18a:Mis18b complex, and that dimerization of M18BP1 is important for its recruitment to centromeres. We show that M18BP1 binds Mis18a:Mis18b through two sub-regions in its N-terminal 140 amino acids. Single CDK phosphorylation sites in each sub-region, Thr40 and Ser110, regulate the interaction, with CDKs phosphorylate CENP-A, HJURP, and M18BP1 to prevent the assembly of the protein complex during the S, G2, and M phases of the cell cycle. Reduced CDK activity in early G1 phase allows the CENP-A deposition machinery to interact and localize to centromeres through the interaction with subunits of CCAN. (B) Schematic diagrams of domain structures of M18BP1, Mis18a, and Mis18b. YP, Yippee domain; CH, C-terminal helix; abBD, Mis18a:Mis18b binding domain. (C) Amylose-resin pull-down assays to identify the Mis18a:Mis18b-binding domain of M18BP1. M18BP1-MBP variants and MBP were produced in bacteria and Mis18a:Mis18b was produced using baculovirus co-expression system. Shown is a representative gel of pull-down assays that were repeated at least three times. The same applies to all other pull-down assays in this paper. (D) Sequence alignment of M18BP1 . Hs, Homo sapiens; Mm, Mus musculus; Bt, Bos taurus; Gg, Gallus gallus; Xl-1, Xenopus laevis isoform 1;
Xl-2, Xenopus laevis isoform 2. Blue-boxed regions indicate putative CDK phosphorylation motifs. Residues that are identical in all sequences are shaded red, and residues that only have conserved substitutions are shaded yellow. (E) Amylose-resin pull-down assays examining how phosphorylation affects complex formation. MBP-M18BP1 variants were incubated with or without CDK1:Cyclin B1 at 30˚C for 2 hr before mixing with Mis18a:Mis18b. Figure 1 continued on next page phosphorylation largely reducing the affinity of M18BP1 for Mis18a:Mis18b, and phosphomimetic mutations abolishing the CENP-A loading activity of M18BP1. Thus, our results identify a mechanism to limit CENP-A loading to the G1 phase of the cell cycle.
Results

M18BP1
1-140 contains two sequential binding regions for Mis18a: Mis18b
We performed amylose-resin pull-down assays with purified M18BP1-MBP (maltose binding protein) fusion variants and Mis18a:Mis18b to identify the M18BP1 sequence responsible for this interaction. The N-terminal 140 residues of M18BP1 were sufficient for Mis18a:Mis18b binding ( Figure 1C . See Supplementary file 1 for a list of constructs used in this study), thus narrowing down the binding site for the Mis18a:Mis18b complex within the N-terminal region of M18BP1 (Ohzeki et al., 2016; Stellfox et al., 2016) . A sequence alignment of vertebrate M18BP1 ( Figure 1D ) revealed that the N-terminal 140 residues of M18BP1 contain two highly conserved CDK phosphorylation motifs at positions Thr40 and Ser110 that are surrounded by other conserved residues, and a less conserved CDK motif at position Thr4. Divergent sequences around residue 50-70 of M18BP1 create a gap separating the two conserved regions. To identify the region responsible for M18BP1 binding, we split M18BP1 1-140 into two fragments (1-60 and 61-140). Both regions retained the ability to bind Mis18a:Mis18b, indicating that each region retains measurable binding affinity for Mis18a:Mis18b, with M18BP1 1-60 binding apparently more strongly than M18BP1 61-140 ( Figure 1E ). We performed pull-down assays with M18BP1 fragments that had been previously phosphorylated with recombinant human CDK1:Cyclin B1. Complete phosphorylation of the fragments was confirmed by mobility shift of the bands on Phos-tag gels. All phosphorylated M18BP1 fragments showed reduced binding affinity for Mis18a:Mis18b compared to the non-phosphorylated fragments ( Figure 1E ).
CENP-A loading assay in HeLa cells
We used the CRISPR/Cas9 system to create an in-frame 3' fusion of the SNAP-tag coding sequence with the endogenous CENP-A coding sequence in a HeLa Flp-In-T-REx cell line (Tighe et al., 2008) . The resulting HeLa CENP-A-SNAP cell line allowed us to perform SNAP-pulse-labeling experiments to examine new CENP-A loading at centromeres (Jansen et al., 2007) . HeLa CENP-A-SNAP cells were treated with M18BP1 siRNA (Fujita et al., 2007) for 48 hr and synchronized at different phases of the cell cycle using thymidine (G1/S transition), S-trityl-L-cysteine (STLC, mitosis), or mitotic-shakeoff. Existing CENP-A-SNAP at the G1/S transition phase after thymidine treatment was blocked using SNAP-Cell Block reagent. After release in the cell cycle, newly loaded CENP-A-SNAP was eventually labeled after cells had transited through mitosis using SNAP-Cell 647-SiR in early G1 phase ( Figure 2A ). Cells treated with M18BP1 siRNA showed clear CENP-A loading defects, whereas control cells showed effective CENP-A loading ( Figure Efficient co-expression with a modified 2A-peptide strategy
Next, we wished to build an approach for testing different segments of M18BP1 for their ability to rescue kinetochore localization of Mis18a:Mis18b and CENP-A-SNAP incorporation in cells depleted of endogenous M18BP1. For this, we modified the 2A-peptide co-expression system to allow coexpression of EGFP-M18BP1 segments and of mCherry-Mis18a. 2A-peptides are 20-amino-acid viral The Phos-tag containing acrylamide gel was used to detect the mobility shift caused by phosphorylation. Gels in panels C and E were stained with CBB. DOI: 10.7554/eLife.23352.002
The following figure supplement is available for figure 1: ( Figure 2B ,E). In the same cells, mCherry-Mis18a showed centromere localization in G1 phase, indicating that EGFP-M18BP1 1-1132 was also able to rescue Mis18a localization ( Figure 2B and F).
Dominant-negative effect of M18BP1 1-140 overexpression
We examined the effects of expressing the Mis18a:Mis18b-binding region of M18BP1 in the CENP-A-SNAP loading assay. HeLa cells expressing EGFP-M18BP1 1-140 showed normal morphology but were unable to load new CENP-A-SNAP onto centromeres, regardless of whether endogenous M18BP1 had been depleted or not ( Figure 2C and E). Both EGFP-M18BP1 1-140 and mCherryMis18a failed to localize to centromeres, suggesting that EGFP-M18BP1 1-140 has a strong dominantnegative effect on the function of endogenous M18BP1 ( Figure 2C , F and G). ( Figure 2D and E). EGFP-M18BP1 141-1132 weakly localized to centromeres, regardless of the depletion of endogenous M18BP1. However, no mCherry-Mis18a recruitment to the centromere was observed in presence of EGFP-M18BP1 141-1132 (upon depletion of endogenous M18BP1), indicating that the interaction with M18BP1 is required for recruitment of Mis18a:Mis18b ( Figure 2D and G).
Phosphorylation on M18BP1 Thr40 and Ser110 prevents Mis18a:Mis18b binding
To confirm that Thr4, Thr40, and Ser110 are the major CDK-phosphorylation sites, we generated a series of non-phosphorylatable M18BP1 mutants by substituting Thr4, Thr40, and Ser110 with either Val or Ala and performed pull-down assays with Mis18a:Mis18b ( Figure 3A ). CDK1-treated T4V and T40V mutants of M18BP1 1-60 showed reduced mobility shift, and a T4V/T40V double mutant of M18BP1 1-60 showed no shift on Phos-tag gels, suggesting Thr4 and Thr40 are the major phosphorylation sites of M18BP1 . The interaction between M18BP1 1-60/T4V and Mis18a:Mis18b was sensitive to CDK-phosphorylation, while the interaction between M18BP1 1-60/T40V and Mis18a:Mis18b
was not affected by CDK activity, indicating that phosphorylation of Thr40 is a determinant of the interaction. Applying the same strategy to the third site, Ser110, we found it to be the only major phosphorylation site within M18BP1 . We observed reduced affinity of M18BP1 61-140/S110A for Mis18a:Mis18b, but the interaction between M18BP1 61-140/S110A and Mis18a:Mis18b was clearly observed in the buffer containing 100 mM NaCl and was not affected by CDK activity. Combining T40V and S110A mutations, we were able to generate a mutant, M18BP1 1-140/T40V/S110A , which was resistant to CDK activity ( Figure 3A) . We then generated a series of phosphomimetic-mutant M18BP1 fragments by substituting Thr4, Thr40, and Ser110 with either Asp or Glu. T4D and T4E mutants of M18BP1 1-60 bound Mis18a:
Mis18b as efficiently as the wild-type construct. T40E mutant of M18BP1 1-60 showed reduced affinity for Mis18a:Mis18b, while the T40D mutant was unable to bind Mis18a:Mis18b. An S110E mutant of M18BP1 61-140 showed stronger reduction of binding affinity for Mis18a:Mis18b than an S110D mutant. Combining the T40D and S110E mutations, we observed a reduction of the affinity of M18BP1 1-140/T40D/S110E for Mis18a:Mis18b comparable to that observed in presence of CDK1:Cyclin B1 ( Figures 3B and 1E ). Using the HeLa CENP-A-SNAP cell line, we determined that the effects of the M18BP1
1-1132/T40D/ S110E on localization and CENP-A incorporation were similar to those observed in presence of EGFP- 
The Mis18a:Mis18b complex is a hexamer
We established a baculovirus system for co-expression of the Mis18a and Mis18b subunits and purified the complex to homogeneity. The Mis18a:Mis18b complex appeared monodisperse in sizeexclusion chromatography (SEC) profiles ( Figure 5A ). We analyzed its stoichiometry with both sedimentation velocity and sedimentation equilibrium analytical ultracentrifugation (AUC) ( Figure Figure 1C ,E. Binding buffer with 300 mM NaCl was used, unless indicated. WT, wild type. DOI: 10.7554/eLife.23352.007
Mis18a:6His-Mis18b complex contains four MBPs, thus demonstrating that the stoichiometry of the Mis18a:Mis18b complex is 4:2 ( Figure 5C-D) . Another notable feature of the Mis18a:Mis18b complex is an elongated conformation, as suggested by the early elution volume of SEC analysis and the high frictional ratio emerging from the AUC analysis in comparison to that of globular standard proteins (Erickson, 2009) .
Nardi and colleagues reported that purified full-length His-Mis18a and Strep-Mis18b form a hetero-tetramer when mixed at a 1:1 molar ratio . Since their experiments were HeLa CENP-A-SNAP + EGFP-M18BP1 1-1132/T40D/S110E -P2A-T2A-mCherry-Mis18α
HeLa CENP-A-SNAP + EGFP-M18BP1 1-140/T40D/S110E -P2A-T2A-mCherry-Mis18α carried out with bacterially expressed proteins, whereas we used proteins expressed in insect cells, we asked if the inconsistency of hydrodynamic analyses resulted from differences in the host used for recombinant expression of the Mis18 complex. We therefore co-expressed 6His-Mis18a and MBP-Mis18b in E. coli with a bicistronic expression system. After removal of affinity tags, the E. coli and insect cell expressed Mis18a:Mis18b complexes showed essentially identical elution profiles in analytical SEC experiments at two different concentrations ( Figure 6A ). The two complexes also behaved essentially identically in sedimentation velocity AUC experiments ( Figure 6B -C and Figure 6-figure supplement 1) . These results are in agreement with our contention that the Mis18 complex is hexameric. Untagged Mis18a and Mis18b were insoluble when expressed in isolation in E. coli (unpublished data), but tagging them with 6His-MBP delivered soluble products. 6His-MBPMis18b appeared monodisperse in analytical SEC experiments, whereas 6His-MBP-Mis18a appeared polydisperse, despite good purity (Figure 6-figure supplement 2) . Removing the 6His-MBP-tag without prior mixing of 6His-MBP-Mis18a and 6His-MBP-Mis18b caused precipitation of both Mis18a and Mis18b, indicative of poor stability of the individual untagged subunits. Tag cleavage after subunit mixing at 1:1 molar ratio yielded (in addition to a precipitate that was removed by centrifugation) Mis18a:Mis18b complex that eluted from an analytical SEC column at the same volume (~1.45 ml) as the Mis18a:Mis18b complex obtained by co-expression in E. coli or insect cells (Figure 6-figure supplement 2 , compare with Figure 6A ). Mixing 6His-MBP-Mis18a and 6His-MBPMis18b at 2:1 molar ratio and cleaving off the tags reduced precipitation and increased the final yield of soluble Mis18a:Mis18b complex, without changing the elution volume of the complex (Figure 6-figure supplement 2A) . Finally, we repeated these SEC experiments using the detergentcontaining SEC buffer reported by Nardi and colleagues , again without observing significant changes in the elution profile of the Mis18a:Mis18b complex ( Figure 6 -figure supplement 2B).
Trimers of C-terminal helices and dimers of Yippee domains mediate hexamer formation
To dissect the mechanism of Mis18 oligomerization, we generated a series of co-expression constructs of Mis18a:Mis18b variants and characterized the purified protein complexes using analytical SEC and sedimentation velocity AUC ( Figure 6A-C had molecular masses consistent with the presence of two Mis18a and one Mis18b subunit ( Figure 6A-C) , indicating that this is the region of the complex that established the 2:1 ratio of the Mis18a and Mis18b subunits. When considering previous evidence that the Mis18a Yippee domain can also homo-dimerize (Subramanian et al., 2016) , we can now propose a schematic model for the Mis18a:Mis18b complex ( Figure 6F ) in which the trimeric C-terminal helices promote the assembly of three dimeric Yippee domain interfaces, two of which being a:b and one being a:a.
To identify the binding site for M18BP1 1-140 on the Mis18a:Mis18b complex, we immobilized MBP-M18BP1 1-140 on an amylose resin and used it as an affinity reagent to pull-down the Mis18a:
Mis18b variants described previously in this section. We found that MBP-M18BP1 1-140 bound the Mis18a:Mis18b Yippee domain dimer but not the C-terminal helices ( Figure 6D ). Binding was specific for the Mis18a:Mis18b heterodimeric arrangement of Yippee domains, because neither 6His-Mis18a 78-191 nor 6His-Mis18b 73-189 bound M18BP1 1-140 in isolation ( Figure 6E ).
Mis18a:Mis18b-mediated dimerization of M18BP1 strengthens centromere association
We were able to reconstitute the core of the Mis18 complex by combining Mis18a:Mis18b with plots of the complexes showed single prominent peaks, suggesting that these samples contain a single predominant species ( Figure 7B ). We conclude that the core of the human Mis18 complex contains four Mis18a subunits, two Mis18b subunits, and binding sites for two M18BP1 N-terminal regions ( Figure 6F ). This binding model predicts that M18BP1 can form dimers in HeLa cells by forming a complex with Mis18a:Mis18b. To test this idea, we generated HeLa CENP-A-SNAP cell lines to co-express EGFP-M18BP1 1-140 and mCherry-M18BP1 1-140 . As negative control, we co-expressed EGFP-M18BP1 1-140/T40D/S110E and mCherry-M18BP1 1-140/T40D/S110E . We performed co-IP experiments with anti-GFP antibody conjugated beads using lysates from these HeLa cell lines previously treated with the CDK1 inhibitor RO-3306. EGFP-M18BP1 1-140 co-immunoprecipitated with mCherry-M18BP1 and Mis18b, while EGFP-M18BP1 1-140/T40D/S110E failed to co-immunoprecipitate with either, indicating that dimerization of M18BP1 1-140 requires binding to Mis18a:Mis18b in HeLa cells ( Figure 7D ).
We asked if the role of the Mis18a:Mis18b complex as a trigger of M18BP1 dimerization could be rescued by fusing M18BP1 to GST, which is known to form homodimers (Kaplan et al., 1997; Lim et al., 1994) . We therefore generated HeLa CENP-A-SNAP cell lines co-expressing GST-EGFP-M18BP1
1-140 and GST-mCherry-M18BP1 1-140 , or GST-EGFP-M18BP1 1-140/T40D/S110E and GSTmCherry-M18BP1 1-140/T40D/S110E . Co-IP experiments showed that GST did not interfere with the interaction of M18BP1 1-140 with Mis18b ( Figure 7D ). As predicted, however, GST rescued the dimerization defect caused by phosphomimetic mutations that prevent the binding of M18BP1 to the Mis18a:Mis18b complex. We hypothesized that a physiological meaning of the Mis18-mediated dimerization of M18BP1 is to strengthen the affinity of the Mis18a:Mis18b complex for centromeres. To test this hypothesis, we asked if forced dimerization with GST rescued the centromere localization defect of M18BP1 mutants rendering it incapable of binding the Mis18 complex. Toward this end, we generated HeLa CENP-A-SNAP cell lines expressing either GST-EGFP- and sufficient for a strong interaction with Mis18a:Mis18b in vitro. This result extends very recent work from two other groups, which, by performing ectopic localization experiments with LacO or tetO arrays, identified a Mis18a:Mis18b binding region in longer N-terminal fragments (1-383 or 1-375) of M18BP1 (Ohzeki et al., 2016; Stellfox et al., 2016) . Previous studies suggested that CDK1 activity regulates CENP-A incorporation into centromeres (McKinley and Cheeseman, 2014; Silva et al., 2012) and that part of this regulation is through phosphorylation of M18BP1, which prevents complex formation with Mis18a:Mis18b (McKinley and Cheeseman, 2014) . However, in the absence of a molecular basis for the interaction of M18BP1 with Mis18a:Mis18b, the details of this regulation had remained unclear. We show that each of the two Mis18a:Mis18b binding regions of M18BP1 (1-60 and 61-140) contains a highly conserved CDK-phosphorylation motif. Using a series of purified M18BP1 proteins with non-phosphorylatable and phosphomimetic mutations, we demonstrated that Thr40 and Ser110 are targets of the CDK1: Cyclin B complex. When introduced in full length M18BP1, the phosphomimetic mutations T40D and S110E reduced recruitment of M18BP1, prevented recruitment of Mis18a to centromeres, and interfered with new CENP-A deposition. These defects are very similar to the defects observed upon expression of EGFP-M18BP1 141-1132 in cells depleted of endogenous M18BP1, and point to M18BP1 1-140 as a controlled interaction module for complex formation with Mis18a:Mis18b.
We used biochemical reconstitution to gain further insights into the organization of the Mis18 complex. The single-peak elution profile from analytical SEC and the single-peak sedimentationcoefficient-distribution profile from AUC of the Mis18a:Mis18b:M18BP1 1-140 -MBP complex indicate that the reconstituted samples are stable and homogeneous. We used these samples to determine the stoichiometry of human Mis18a:Mis18b and of the Mis18 core complex by Stankovic et al., 2016 AUC. The Mis18a:Mis18b complex is a hexamer containing four Mis18a and two Mis18b subunits, and it binds two M18BP1 1-140 subunits. The functional importance of oligomerization of Mis18a and Mis18b for CENP-A loading has been highlighted in two additional recent studies Subramanian et al., 2016) . The single fission yeast ortholog of Mis18 uses both the Yippee and the C-terminal coiled-coil domains to form homo tetramers (Subramanian et al., 2016) . Fulllength human Mis18a and Mis18b, on the other hand, have been reported to oligomerize via their C-terminal coiled-coil domains to form 2:2 heterotetramer . Our results are inconsistent with this recent report. Nardi et al. (2016) derived the molecular mass of the Mis18a: Mis18b complex through the Siegel-Monty equation (Siegel and Monty, 1966 ) with estimates of the Stokes radius (from SEC experiments) and of the sedimentation coefficient (from glycerol-gradient ultracentrifugation experiments) derived from Western blot analysis of SDS-PAGE, an approach that we deem more error prone in comparison to our combined sedimentation velocity and sedimentation equilibrium AUC analyses. We show that recombinant Mis18a:Mis18b complexes produced in insect cells and E coli have essentially identical hydrodynamic properties in different buffers and concentrations. Thus, the hexamer is the prevalent form of the Mis18a:Mis18b complex. Our biochemical assays show that the Yippee domains of Mis18a and Mis18b are both required for achieving a strong interaction with M18BP1 1-140 . This suggests that the stoichiometry of Mis18b in the Mis18 complex limits the number of bound M18BP1, because two Mis18a:Mis18b Yippee domain hetero-dimers can be formed in one hexamer, and each can bind a copy of M18BP1 1-140 .
Our results are consistent with evidence that M18BP1 interacts with the Mis18a:Mis18b complex only when both Mis18a and Mis18b subunits are co-expressed in a yeast-three-hybrid assay (Fujita et al., 2007) . The 4:2:2 stoichiometry of the Mis18 complex likely provides a base to understand the assembly of the CENP-A loading machinery, and further structural analysis will have to examine the details of this unique octameric complex. Overexpression of EGFP-M18BP1 1-140 in HeLa cells had a strong dominant-negative effect on centromere localization of Mis18a:Mis18b and on CENP-A loading, suggesting that EGFP-M18BP1
1-140 binds to Mis18a:Mis18b in HeLa cells and prevents its interaction with endogenous M18BP1.
This result also indicates that the complex of EGFP-M18BP1 1-140 with Mis18a:Mis18b cannot localize to centromeres. Indeed, we observed that M18BP1 141-1132 , which is unable to bind with Mis18a:
Mis18b, localized to centromeres, although weakly, arguing that M18BP1 141-1132 contains interaction modules for autonomous localization to centromeres. Mouse M18BP1 and frog M18BP1 isoforms were shown to interact with the CCAN protein CENP-C (Dambacher et al., 2012; Moree et al., 2011 ) through a binding domain located between the SANTA and SANT domains (Dambacher et al., 2012; Stellfox et al., 2016) . We demonstrated that forced dimerization of M18BP1 141-1132 using GST-tag increased its localization to centromeres in HeLa cells, supporting the hypothesis that Mis18a:Mis18b-mediated dimerization of M18BP1 is required to strengthen the interaction between the Mis18 complex and centromeric recruiters. However, GST-mediated dimerization did not rescue centromeric localization of EGFP-M18BP1 141-1132 to the levels of full length EGFP-M18BP1, indicating that the interaction with Mis18a:Mis18b contributes to the localization mechanism even beyond dimerization. A physical interaction of Mis18b with the CENP-C C-terminal region might account for increased binding affinity . Combining our findings with those of recent studies Ohzeki et al., 2016; Stellfox et al., 2016; Subramanian et al., 2016) , we conclude that full assembly of the Mis18 complex is important for its function. Our analysis demonstrates that the phosphorylation of Thr40 and Ser110 of M18BP1 by CDK1 prevents assembly of the Mis18 complex, thus describing a crucial mechanism to temporally restrict CENP-A loading to early G1 phase, when the levels of Cyclin B rapidly decline after their mitotic peak. In conclusion, the available evidence depicts a complex binding mechanism for the centromere localization of the Mis18 complex, with multiple binding interfaces and a complex regulation by mitotic kinases. Here, we have dissected the regulation of a crucial element of this interface.
Materials and methods
Plasmids
Plasmid pETDuet-8His was generated from pETDuet-1 (Novagen) by adding the coding DNA sequence (CDS) of 8His-tag immediately after the XhoI site using an modified inverse PCR method (Erster and Liscovitch, 2010) . Plasmid pETDuet-MBP-8His was generated by inserting the CDS of MBP (E. coli malE Lys27-Lys396) followed by a tobacco etch virus (TEV) protease cleavage-site between NcoI and XhoI sites of pETDuet-8His. Restriction sites of BglII and NcoI in the CDS of MBP were removed and two mutations (A312V/I317V) (Walker et al., 2010) were introduced into MBP with a site-directed mutagenesis PCR method (Sawano and Miyawaki, 2000) . Codon-optimized cDNA of human M18BP1 was purchased from GeneArt. The CDSs of M18BP1 fragments were subcloned into pETDuet-MBP-8His plasmid between TEV-protease cleavage site and 8His-tag using BamHI and XhoI sites to generate pETDuet-MBP-M18BP1-8His plasmids. Plasmid pGEX6PT-M18BP1 1-1132 -MBP was generated by inserting the CDS of a TEV-protease cleavage site followed by M18BP1 and MBP (modified sequence described above) between BamHI and NotI sites of pGEX-6P-1 (GE Healthcare). The original BamHI site of pGEX-6P-1 was removed by ligation with BglII site while a new BamHI site was introduced after the TEV-protease cleavage site. A XhoI site was introduced between M18BP1 and MBP to enable subcloning of M18BP1 fragments using BamHI and XhoI sites. Mutations were introduced using the PCR method (Sawano and Miyawaki, 2000) . Codon-optimized cDNAs of human Mis18a and Mis18b were purchased from GeneArt. Plasmid pLIB-6His-Mis18a (or Mis18b) was generated by inserting the CDS of 6His-tag followed by a TEVprotease cleavage site and Mis18a (or Mis18b) between BamHI and SalI sites of pLIB (Weissmann et al., 2016) . Plasmid pLIB-MBP-Mis18a (or Mis18b) was generated by inserting the CDS of MBP followed by a TEV-protease cleavage site and Mis18a (or Mis18b) between BamHI and SalI sites of pLIB. In these constructs, the original BamHI site of pLIB was abolished by ligation with BglII site while a new BamHI site was introduced after the TEV-protease cleavage site. Plasmid pLIBMis18b was generated by inserting the CDS of Mis18b between BamHI and SalI sites of pLIB. Coexpression plasmids for baculovirus expression (pBIG1e-6His-Mis18a:Mis18b, pBIG1e-6His-Mis18a: MBP-Mis18b, pBIG1e-6His-Mis18b:MBP-Mis18a) were generated by ligating the DNA fragments of two expression cassettes amplified from pLIB plasmids described above with the pBIG1e backbone (Weissmann et al., 2016) . E. coli co-expression plasmids of pETDuet-6His-Mis18a-MBP-Mis18b variants were generated by inserting the CDS of Mis18a (or its variants) followed by a ribosome-binding site, the CDSs of MBP and Mis18b (or its variants) between BamHI and XhoI sites of pETDuet-1. TEV-protease cleavage sites were introduced both between 6His and Mis18a and between MBP and Mis18b for removal of 6His-tag and MBP-tag during protein purification. was generated by inserting the CDS of mCherry into the plasmid pETDuet-6His-Mis18a at the C-terminal side of Mis18a .
Plasmids pETDuet-6His-Mis18a were generated by inserting the CDS of a TEV-protease cleavage site followed by the CDS of Mis18a between BamHI and XhoI sites of pETDuet-1. plasmids pETDuet-6His-MBP-Mis18a and pETDuet6His-MBP-Mis18b were generated by inserting the CDS of MBP followed by a TEV-protease cleavage site and Mis18a or Mis18b between BamHI and XhoI sites of pETDuet-1. Codon-optimized cDNAs of human CDK1 and Cyclin B1 were obtained from GeneArt. The CDSs of CDK1 and Cyclin B1 were individually subcloned in pLIB with N-terminal GST-and 6His-tag, respectively. They were then subcloned in pBIG1a to generate pBIG1a -GST-CDK1:6His-Cyclin-B1.
Plasmid pcDNA5-EGFP-NLS-P2AT2A-mCherry-PTS1 was generated by inserting the CDS of EGFP-NLS-P2AT2A-mCherry-PTS1 between BamHI and BclI of pcDNA5/FRT/TO (Thermo Fisher Scientific). The original BamHI site of pcDNA5/FRT/TO was removed by ligation with BglII site, while a new BamHI site was introduced after the CDS of EGFP. The CDS of NLS can be replaced with the CDS of a protein of interest using BamHI and XhoI sites. The CDS of peroxisomal targeting signal-1 (PTS1) can be replaced with the CDS of a protein of interest using NheI and XmaI sites. Plasmid pcDNA5-MTS-TagBFP-EGFP-NLS-P2AT2A-mCherry-PTS1 was generated by inserting the CDS of mitochondrial targeting signal (MTS) fused TagBFP (Evrogen) (MTS-TagBFP) followed by P2AT2A to the upstream of the EGFP of pcDNA5-EGFP-NLS-P2AT2A-mCherry-PTS1.
Plasmids pcDNA5-EGFP-M18BP1-P2AT2A-mCherry-Mis18a variants were generated by replacing the CDSs of NLS and PTS1 of pcDNA5-EGFP-NLS-P2AT2A-mCherry-PTS1 with these of M18BP1 variants and Mis18a, respectively, using the restriction sites described above. No stop codon was placed between the CDSs of M18BP1 and P2AT2A. Plasmids pcDNA5-GST-EGFP-M18BP1(1-1132)-P2AT2A-mCherry-Mis18a and pcDNA5-GST-EGFP-M18BP1(141-1132)-P2AT2A-mCherry-Mis18a were generated by inserting the CDS of GST between HindIII and KpnI sites of pcDNA5-EGFP-M18BP1(1-1132)-P2AT2A-mCherry-Mis18a and pcDNA5-EGFP-M18BP1(141-1132)-P2AT2A-mCherry-Mis18a. Plasmids pcDNA5-EGFP-M18BP1(1-140)-P2AT2A-mCherry-M18BP1(1-140) and pcDNA5-EGFP-M18BP1(1-140/T40D/S110E)-P2AT2A-mCherry-M18BP1(1-140/T40D/S110E) were generated by replacing the CDS of Mis18a with the CDS of M18BP1(1-140) or M18BP1(1-140/ T40D/S110E).
Plasmid pETDuet-CENP-A-SNAP-HA-PGK-NeoR was generated by ligating four DNA fragments (1 kb CENP-A gene sequence upstream form the stop codon, the CDS of SNAP-3HA, PGK promoter with neomycin resistant gene (NeoR), 1 kb CENP-A gene sequence downstream form the stop codon) and pETDuet backbone treated with XbaI and XhoI restriction enzymes using Gibson cloning method (Gibson et al., 2009) . The CDS of SNAP-3HA was amplified from the pSS26m plasmid containing the CDS of CENP-A-SNAP-3HA, which was a gift from L.E.T. Jansen (Instituto Gulbenkian de Ciê ncia, Portugal) (Jansen et al., 2007) .
Plasmid pX330-CENP-A-sgRNA was generated by inserting annealed oligos (5'-CACCGCGAG TCCCTCCTCAAGGCCC-3', 5'-AAACGGGCCTTGAGGAGGGACTCGC-3') into BbsI sites of pX330 (Ran et al., 2013) , which was purchased from Addgene.
All constructs were verified by DNA sequencing before being used for protein expression or as the templates for PCR. The list of all plasmids used in this study is presented in Supplementary file 1.
Protein expression
E. coli cells of BL21-CodonPlus(DE3)-RIL strain transformed with expression plasmids were cultured in 2xYT media (16 g/L tryptone, 10 g/L yeast extract, 5 g/L NaCl) supplemented with ampicillin and chloramphenicol at 37˚C. Protein expression was induced by adding IPTG to the final concentration of 0.2 mM when OD 600 of the culture reached 0.6 and further incubation at 20˚C for 16 hr.
Plasmids of pBIG1 derivatives carrying expression cassettes were recombined to baculoviral genome by Tn7 transposition in E. coli DH10EMBacY cells (Trowitzsch et al., 2010) . Recombined EMBacY with expression cassettes were extracted from bacteria cells and used to transfect Sf9 cells for baculovirus generation. Initial viruses were obtained after 3 days incubation of EMBacY and Sf9 cells with FuGENE reagent (Promega). Viruses were amplified using Sf9 cells. Litter-scale protein expression was performed by incubation of viruses and Tnao38 cells at 27˚C for 4 days with starting density of 1.2 million Tnao38 cells per mL of Sf-900 III SFM media (Thermo Fisher Scientific).
Protein purification
All purification procedures were performed either on ice or at 4˚C. C-terminal MBP-tagged M18BP1 protein samples were purified from E. coli cells expressing GST-M18BP1-MBP variants. The cells were suspended in buffer containing 50 mM HEPES pH 7.5, 500 mM NaCl, 1 mM tris(2-carboxyethyl)phosphine hydrochloride (TCEP) and 1 mM PMSF and lysed by sonication. The clear supernatant obtained after centrifugation was incubated with glutathione sepharose resin (GE Healthcare) for~16 hr. Protein-bound resin was washed with 100 column volumes of buffer A and incubated for~16 hr with His-tagged TEV protease (His-TEVp) for on-resin cleavage at a stoichiometry of 1/10 with respect to the expected yield of the GST-M18BP1-MBP variant. His-TEVp cut between GST and M18BP1. Eluted M18BP1-MBP variant was separated using Ni resin (cOmplete His-tag purification resin, Roche) from His-TEVp and concentrated to more than 5 mg/ml. N-terminal MBP-tagged M18BP1 protein samples were purified from E. coli cells expressing MBP-M18BP1-8His variants. The cells were suspended in buffer HST300 (30 mM HEPES pH 7.5, 300 mM NaCl, 1 mM TCEP) containing 1 mM PMSF and 10 mM imidazole and lysed by sonication. The clear supernatant obtained after centrifugation was incubated with Ni resin (Roche) for~16 hr. Protein-bound resin was washed with 100 column volumes of buffer HST300 containing 10 mM imidazole. MBP-M18BP1-8His variants were eluted with 10 column volumes of buffer HST300 containing 400 mM imidazole and concentrated in buffer HST300 to more than 5 mg/ml. The concentration of imidazole were reduced to less than 10 mM by repetition twice of dilution of the concentrated protein sample with 10 times buffer HST300. MBP-8His was purified in the same way as MBP-M18BP1-8His.
Insect-cell-expressed Mis18a:Mis18b complex was purified from Tnao38 cells co-expressing 6His-tagged Mis18a and untagged Mis18b. The cells were suspended in buffer HST300 containing 10 mM imidazole and subjected to Ni-affinity purification using the same procedure as for purification of MBP-M18BP1-8His. Concentrated 6His-Mis18a:Mis18b complex was incubated with His-TEVp for~16 hr to cleave off the His-tag. Mis18a:Mis18b complex was further purified using Superdex 200 10/300 GL SEC column (GE Healthcare) and concentrated to 5 mg/mL in buffer HST300. E. coliexpressed Mis18a:Mis18b variants were purified using the same procedure as for purification of insect-cell-expressed Mis18a:Mis18b complex. MBP-Mis18a:6His-Mis18b and 6His-Mis18a:MBPMis18b complexes were also purified from Tnao38 cells using the same procedure as for purification of Mis18a:Mis18b complex without the step of tag-cleavage using His-TEVp.
Purified Mis18a:Mis18b complex (insect cell expression) was incubated with 1.5-2 times of (molar ratio) M18BP1
1-140 -MBP or M18BP1 1-228 -MBP in buffer HST300. The Mis18a:Mis18b:M18BP1 Nterminus MBP complexes were separated from excess M18BP1 1-140 -MBP or M18BP1 1-228 -MBP using SEC with Superdex 200 10/300 GL SEC column equilibrated in buffer HST300. GST-CDK1:6His-Cyclin B1 was purified from Tnao38 cells using glutathione Sepharose (GE Healthcare) followed by size exclusion chromatography using HiLoad 16/60 Superdex 200 pg column (GE Healthcare) equilibrated in buffer containing 20 mM HEPES pH 7.5, 200 mM NaCl, 1 mM TCEP, and 5% glycerol.
Phosphorylation using CDK1:Cyclin B1
Purified MBP-M18BP1-8His variants and MBP-8His were incubated at the concentration of 10 mM with 50 nM GST-CDK1:6His-Cyclin B1 complex in the reaction solution containing 20 mM HEPES pH 7.5, 300 mM NaCl, 1 mM TCEP, 5 mM ATP, and 10 mM MgCl 2 at 30˚C for 2 hr.
Pull down assays using amylose resin
Proteins were diluted to 3 mM in 40 mL buffer HST300, unless otherwise noted, and mixed with 20 mL amylose resin (NEB) equilibrated with buffer HST300 or buffer with reduced NaCl concentration of 100 mM. One-third of this mixture was taken as input fraction and the rest two-thirds were incubated at 4˚C for 30 min. Amylose-bound proteins were separated from unbound fraction by spinning down the amylose resin and washing with 500 mL buffer HST300 four times. The input and bound fractions were analyzed by Tricine-SDS-PAGE using normal gels and Phos-tag gels. The gels were stained with Coomassie brilliant blue (CBB). Phos-tag acrylamide gels containing 50 mM Phos-tag AAL-107 (NARD institute) were prepared according to the manufacture's protocol and were used to detect the mobility shift caused by phosphorylation.
Generation of HeLa cell lines
A HeLa CENP-A-SNAP cell line was directly generated from a Flp-In T-REx HeLa cell line generated by Stephen Taylor and colleagues (Tighe et al., 2008) , which we did not further authenticate. All cell lines are described in Supplementary file 2. We tagged the C-terminus of endogenous CENP-A loci with a SNAP-3HA-tag using CRISPR/Cas9-mediated genome engineering following the protocol previously described (Ran et al., 2013) with modifications. The Flp-In T-REx HeLa cells were transfected with pX330-CENP-A-sgRNA together with the PCR-amplified rescue DNA fragment from pETDuet-CENP-A-SNAP-HA-PGK-NeoR that contained the CDS of SNAP-3HA-PGK-NeoR with 1 kb CENP-A genomic DNA flanking both sides. The positive clones were selected using G418, and the correct tagging was verified by confirming the centromere labeling of the early G1 cells with SNAP-Cell 647-SiR (NEB).
HeLa CENP-A-SNAP cell lines co-expressing EGFP-M18BP1 variants and mCherry-Mis18a were generated by transfecting the HeLa CENP-A-SNAP cells with pcDNA5-EGFP-M18BP1-P2AT2A-mCherry-Mis18a plasmids and pOG44 plasmid according to the protocol previously described (Tighe et al., 2004 (Tighe et al., , 2008 . HeLa cell lines co-expressing EGFP-NLS and mCherry-PTS1 with or without MTS-TagBFP were generated by transfecting the Flp-In T-REx HeLa cells with the pcDNA5-EGFP-NLS-P2AT2A-mCherry-PTS1 derived plasmids using the same protocol described above. Cell lines were regularly tested for mycoplasma contamination and tests found negative.
CENP-A loading experiment
HeLa cells were placed in wells of 12-well plates in DMEM (PAN Biotech) supplemented with 10% tetracycline-free FBS (Thermo Fisher Scientific, Waltham, MA) and 2 mM l-glutamine (PAN-Biotech) and grown at 37˚C in the presence of 5% CO 2 for 24 hr. Then, the cells were treated with Lipofectamine RNAiMAX, serum-free OptiMEM (Thermo Fisher Scientific), 10 nM M18BP1 siRNA (5'-GAAG UCUGGUGUUAGGAAAdTdT-3') (Fujita et al., 2007) for 48 hr according to the manufacture's protocol, and the control cells were treated with Lipofectamine RNAiMAX and serum-free OptiMEM without siRNA. Doxycycline (Sigma) was added to the culture at a concentration of 50 ng/ml to induce protein expression and was kept in the media until the fixation of cells. Thymidine (1 mM final concentration) was used to arrest cells at S/G1 transition phase. When cells were released from thymidine, existing CENP-A-SNAP proteins were blocked using SNAP-Cell Block (NEB) according to the manufacture's protocol. STLC (5 mM final concentration) was used to arrest cells in prometaphase. The cells arrested in prometaphase were separated from other cells by mitotic-shake-off, released from STLC by extensive wash with the media and placed in wells of 24-well plates containing poly-lysine coated coverslips. Three hours later, the cells in early G1 phase attached on the coverslips and were treated with SNAP-Cell 647-SiR (NEB) to label newly synthesized CENP-A-SNAP according to the manufacture's protocol. Cells were fixed with PBS/PHEM (Pipes, Hepes, EGTA, and MgCl 2 )-paraformaldehyde 4% followed by permeabilization with PBS/PHEM-Triton X-100 0.5% and immunostaining. The following antibodies were used for immunostaining: CREST/anticentromere antibodies (human autoimmune serum, Antibodies, Inc.), anti-M18BP1 (Bethyl A302-825A), anti-rabbit Rodamine red-conjugated, anti-human DyLight 405-conjugated secondary antibodies were purchased from Jackson ImmunoResearch Laboratories, Inc. Coverslips were mounted with Mowiol mounting media (EMD Millipore) and imaged using a 60Â oil immersion objective lens on a DeltaVision deconvolution microscope. Quantification of centromere signals were performed using the software Fiji with a script from a previous study with modifications for semiautomated processing. Briefly, average projections were made from z-stacks of recorded images. Centromere spots were chosen based on the parameters of shape, size, and intensity using the images obtained with CREST-staining, and their positions were recorded. The mean intensity value of adjacent pixels of a centromere spot was subtracted as background intensity from the mean intensity value of the centromere spot. Statistical analysis of the quantified intensity was performed and the plots were generated with the software Prism 7 (GraphPad Software Inc.).
Co-immunoprecipitation experiment
HeLa cells were grown in DMEM supplemented with 10% tetracycline-free fetal bovine serum, 1% L-glutamine and 1% Penicillin-Streptomycin at 37˚C in a 5% CO 2 atmosphere. Cells were treated with 50 ng/mL doxycycline (Sigma) for 18 hr and then treated with both 50 ng/mL doxycycline and 9
